A citation-based method for searching scientific literature

C Lerman, J Seay, A Balshem, J Audrain. Am J Med Genet 1995
Times Cited: 263







List of co-cited articles
542 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Attitudes about genetic testing for breast-ovarian cancer susceptibility.
C Lerman, M Daly, A Masny, A Balshem. J Clin Oncol 1994
434
41

Anticipated uptake and impact of genetic testing in hereditary breast and ovarian cancer families.
J P Struewing, C Lerman, R G Kase, T R Giambarresi, M A Tucker. Cancer Epidemiol Biomarkers Prev 1995
184
26

BRCA1 testing in families with hereditary breast-ovarian cancer. A prospective study of patient decision making and outcomes.
C Lerman, S Narod, K Schulman, C Hughes, A Gomez-Caminero, G Bonney, K Gold, B Trock, D Main, J Lynch,[...]. JAMA 1996
604
23

Decision-making about genetic testing among women at familial risk for breast cancer.
P B Jacobsen, H B Valdimarsdottier, K L Brown, K Offit. Psychosom Med 1997
127
18

A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.
Y Miki, J Swensen, D Shattuck-Eidens, P A Futreal, K Harshman, S Tavtigian, Q Liu, C Cochran, L M Bennett, W Ding. Science 1994
16

Attitudes towards cancer predictive testing and transmission of information to the family.
C Julian-Reynier, F Eisinger, P Vennin, F Chabal, Y Aurran, C Noguès, Y J Bignon, M Machelard-Roumagnac, C Maugard-Louboutin, D Serin,[...]. J Med Genet 1996
100
16

Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing.
C Lerman, B Biesecker, J L Benkendorf, J Kerner, A Gomez-Caminero, C Hughes, M M Reed. J Natl Cancer Inst 1997
276
14

Attitudes and interest in genetic testing for breast and ovarian cancer susceptibility in diverse groups of women in western Washington.
S J Durfy, D J Bowen, A McTiernan, J Sporleder, W Burke. Cancer Epidemiol Biomarkers Prev 1999
145
13

Women's interest in genetic testing for breast cancer risk: the influence of sociodemographics and knowledge.
Joan L Bottorff, Pamela A Ratner, Lynda G Balneaves, Chris G Richardson, Mary McCullum, Tom Hack, Karen Chalmers, Jane Buxton. Cancer Epidemiol Biomarkers Prev 2002
63
20


Women's receptivity to testing for a genetic susceptibility to breast cancer.
H Chaliki, S Loader, J C Levenkron, W Logan-Young, W J Hall, P T Rowley. Am J Public Health 1995
128
12

Factors associated with decisions about clinical BRCA1/2 testing.
K Armstrong, K Calzone, J Stopfer, G Fitzgerald, J Coyne, B Weber. Cancer Epidemiol Biomarkers Prev 2000
101
12

Identification of the breast cancer susceptibility gene BRCA2.
R Wooster, G Bignell, J Lancaster, S Swift, S Seal, J Mangion, N Collins, S Gregory, C Gumbs, G Micklem. Nature 1995
11

Presymptomatic DNA testing and prophylactic surgery in families with a BRCA1 or BRCA2 mutation.
E J Meijers-Heijboer, L C Verhoog, C T Brekelmans, C Seynaeve, M M Tilanus-Linthorst, A Wagner, L Dukel, P Devilee, A M van den Ouweland, A N van Geel,[...]. Lancet 2000
225
11

Psychological responses to BRCA1 mutation testing: preliminary findings.
R T Croyle, K R Smith, J R Botkin, B Baty, J Nash. Health Psychol 1997
243
11

Impact of Event Scale: a measure of subjective stress.
M Horowitz, N Wilner, W Alvarez. Psychosom Med 1979
11

Attitudes, knowledge, and risk perceptions of women with breast and/or ovarian cancer considering testing for BRCA1 and BRCA2.
L G Bluman, B K Rimer, D A Berry, N Borstelmann, J D Iglehart, K Regan, J Schildkraut, E P Winer. J Clin Oncol 1999
106
10

Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients.
Erna Claes, Gerry Evers-Kiebooms, Andrea Boogaerts, Marleen Decruyenaere, Lieve Denayer, Eric Legius. Am J Med Genet A 2003
163
10

Genetic testing: psychological aspects and implications.
Caryn Lerman, Robert T Croyle, Kenneth P Tercyak, Heidi Hamann. J Consult Clin Psychol 2002
178
10

Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families.
B B Biesecker, N Ishibe, D W Hadley, T R Giambarresi, R G Kase, C Lerman, J P Struewing. Am J Med Genet 2000
92
10

Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.
D Ford, D F Easton, M Stratton, S Narod, D Goldgar, P Devilee, D T Bishop, B Weber, G Lenoir, J Chang-Claude,[...]. Am J Hum Genet 1998
10



Why do women attend familial breast cancer clinics?
K Brain, J Gray, P Norman, E Parsons, A Clarke, C Rogers, R Mansel, P Harper. J Med Genet 2000
85
11

Intention to pursue genetic testing for breast cancer among women due for screening mammography.
Karin Gwyn, Sally W Vernon, Patrick M Conoley. Cancer Epidemiol Biomarkers Prev 2003
36
25

To tell or not to tell: barriers and facilitators in family communication about genetic risk.
K Forrest, S A Simpson, B J Wilson, E R van Teijlingen, L McKee, N Haites, E Matthews. Clin Genet 2003
244
9

A descriptive study of BRCA1 testing and reactions to disclosure of test results.
H T Lynch, S J Lemon, C Durham, S T Tinley, C Connolly, J F Lynch, J Surdam, E Orinion, S Slominski-Caster, P Watson,[...]. Cancer 1997
169
9



Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study.
Iris van Oostrom, Hanne Meijers-Heijboer, Litanja N Lodder, Hugo J Duivenvoorden, Arthur R van Gool, Caroline Seynaeve, Conny A van der Meer, Jan G M Klijn, Bert N van Geel, Curt W Burger,[...]. J Clin Oncol 2003
195
9

How families communicate about HNPCC genetic testing: findings from a qualitative study.
Susan K Peterson, Beatty G Watts, Laura M Koehly, Sally W Vernon, Walter F Baile, Wendy K Kohlmann, Ellen R Gritz. Am J Med Genet C Semin Med Genet 2003
112
8

All in the family: evaluation of the process and content of sisters' communication about BRCA1 and BRCA2 genetic test results.
Chanita Hughes, Caryn Lerman, Marc Schwartz, Beth N Peshkin, Lari Wenzel, Steven Narod, Camille Corio, Kenneth P Tercyak, Danielle Hanna, Claudine Isaacs,[...]. Am J Med Genet 2002
156
8

Awareness and attitudes concerning BRCA gene testing.
A Mogilner, M Otten, J D Cunningham, S T Brower. Ann Surg Oncol 1998
48
16

Genetic testing in families with hereditary nonpolyposis colon cancer.
C Lerman, C Hughes, B J Trock, R E Myers, D Main, A Bonney, M R Abbaszadegan, A E Harty, B A Franklin, J F Lynch,[...]. JAMA 1999
176
8

Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies.
A Antoniou, P D P Pharoah, S Narod, H A Risch, J E Eyfjord, J L Hopper, N Loman, H Olsson, O Johannsson, A Borg,[...]. Am J Hum Genet 2003
8

Psychological distress and surveillance behaviors of women with a family history of breast cancer.
K M Kash, J C Holland, M S Halper, D G Miller. J Natl Cancer Inst 1992
432
8


Ethnic differences in knowledge and attitudes about BRCA1 testing in women at increased risk.
C Hughes, A Gomez-Caminero, J Benkendorf, J Kerner, C Isaacs, J Barter, C Lerman. Patient Educ Couns 1997
163
8

Clinical characteristics of individuals with germline mutations in BRCA1 and BRCA2: analysis of 10,000 individuals.
Thomas S Frank, Amie M Deffenbaugh, Julia E Reid, Mark Hulick, Brian E Ward, Beth Lingenfelter, Kathi L Gumpper, Thomas Scholl, Sean V Tavtigian, Dmitry R Pruss,[...]. J Clin Oncol 2002
641
8

The influence of psychological distress on use of genetic testing for cancer risk.
C Lerman, M D Schwartz, T H Lin, C Hughes, S Narod, H T Lynch. J Consult Clin Psychol 1997
139
8


Psychosocial aspects of cancer genetics: women at high risk for breast and ovarian cancer.
K M Kash, K Ortega-Verdejo, M K Dabney, J C Holland, D G Miller, M P Osborne. Semin Surg Oncol 2000
33
24


Family Communication and Genetic Counseling: The Case of Hereditary Breast and Ovarian Cancer.
J Green, M Richards, F Murton, H Statham, N Hallowell. J Genet Couns 1997
122
7

The impact of genetic counselling on risk perception and mental health in women with a family history of breast cancer.
M Watson, S Lloyd, J Davidson, L Meyer, R Eeles, S Ebbs, V Murday. Br J Cancer 1999
184
7



BRCA1/2 predictive testing: a study of uptake in two centres.
Lucy Brooks, Fiona Lennard, Andrew Shenton, Fiona Lalloo, Ingrid Ambus, Audrey Ardern-Jones, Rachel Belk, Bronwyn Kerr, David Craufurd, Rosalind Eeles,[...]. Eur J Hum Genet 2004
43
16

Psychological and social determinants of women's decisions to undergo genetic counseling and testing for breast cancer.
M Cappelli, L Surh, L Humphreys, S Verma, D Logan, A Hunter, J Allanson. Clin Genet 1999
92
7

Anticipated versus actual emotional reactions to disclosure of results of genetic tests for cancer susceptibility: findings from p53 and BRCA1 testing programs.
M Dorval, A F Patenaude, K A Schneider, S A Kieffer, L DiGianni, K J Kalkbrenner, J I Bromberg, L A Basili, K Calzone, J Stopfer,[...]. J Clin Oncol 2000
100
7


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.